Breaking News Headlines Today | Ground News

See every side of every news story

cancernetwork.com image

News from cancernetwork.com

Ground News rates cancernetwork.com’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Is cancernetwork.com credible or reliable? Our Factuality score answers both of those questions. When it comes to cancernetwork.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about cancernetwork.com

Where is cancernetwork.com located?cancernetwork.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top cancernetwork.com News

Trispecific Antibody Earns FDA Fast Track Designation in Multiple Myeloma

San Francisco, California · San Francisco

Trispecific Antibody Earns FDA Fast Track Designation in Multiple Myeloma

82% Center coverage: 11 sources

Investigators are currently assessing IBI3003 among patients with relapsed/refractory multiple myeloma in a phase 1/2 trial.See the Story

Curbing your drinking? This number of drinks raises colon cancer risk — Two refreshing cocktails with citrus and umbrellas, perfect for a summer day outdoors. by Burst/Pexels / Pexels

Cancer · United States

Curbing your drinking? This number of drinks raises colon cancer risk

Coverage: 8 sources

New research, published Jan. 26 in the American Cancer Society's peer-reviewed journal Cancer, found drinkers with an average lifetime alcohol intake of 14 or more drinks per week had a 25% higher risk of developing colorectal cancer and a 95% higher risk of developing rectal cancer compared to those with an average of less than one drink per week. See the Story

DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

United States · United States

DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

42% Center coverage: 7 sources

/PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and...See the Story

Breaking News Topics Related to cancernetwork.com